company background image
524280 logo

Kopran BSE:524280 Stock Report

Last Price

₹259.60

Market Cap

₹12.5b

7D

8.8%

1Y

41.7%

Updated

14 Jun, 2024

Data

Company Financials

524280 Stock Overview

An integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally.

524280 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends3/6

Kopran Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Kopran
Historical stock prices
Current Share Price₹259.60
52 Week High₹292.40
52 Week Low₹160.00
Beta0.51
1 Month Change4.15%
3 Month Change0.27%
1 Year Change41.74%
3 Year Change30.39%
5 Year Change651.37%
Change since IPO218.33%

Recent News & Updates

Recent updates

Shareholder Returns

524280IN PharmaceuticalsIN Market
7D8.8%2.8%3.7%
1Y41.7%54.0%44.7%

Return vs Industry: 524280 underperformed the Indian Pharmaceuticals industry which returned 54% over the past year.

Return vs Market: 524280 underperformed the Indian Market which returned 44.7% over the past year.

Price Volatility

Is 524280's price volatile compared to industry and market?
524280 volatility
524280 Average Weekly Movement6.9%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.6%
10% most volatile stocks in IN Market9.6%
10% least volatile stocks in IN Market4.3%

Stable Share Price: 524280 has not had significant price volatility in the past 3 months.

Volatility Over Time: 524280's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1958902Surendra Somaniwww.kopran.com

Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as topical preparations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-histamine, anti-acne, anti-infective, urological, anti-thrombotic, antidiabetic, pain management, gastroenterology, and cardiovascular.

Kopran Limited Fundamentals Summary

How do Kopran's earnings and revenue compare to its market cap?
524280 fundamental statistics
Market cap₹12.52b
Earnings (TTM)₹509.56m
Revenue (TTM)₹6.15b

24.6x

P/E Ratio

2.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
524280 income statement (TTM)
Revenue₹6.15b
Cost of Revenue₹4.02b
Gross Profit₹2.13b
Other Expenses₹1.62b
Earnings₹509.56m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)10.57
Gross Margin34.60%
Net Profit Margin8.29%
Debt/Equity Ratio20.2%

How did 524280 perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

28%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.